Herzog J, Farber J L
Cancer Res. 1976 May;36(5):1761-70.
Dimethylnitrosamine maximally inhibits rat liver nuclear RNA synthesis by 50% at a dose of 40 mg/kg of body weight. The inhibition develops during the first 4 hr and persists through the 12th hr. All parenchymal cells of the lever lobule seem to be affected. The decreased RNA synthesis can be accounted for entirely by an inhibition of the RNA polymerase activities quantitatively solubilized and partially purified. A similar inhibition of the polymerase activities was demonstrated in the intact nuclei by inactivating the endogenous template with actinomycin D and assaying the polymerases with an added exogenous template, poly(deoxy-adenylate-deoxythymidylate). Chromatin was prepared by two methods differing in the extent to which they remove the endogenous polymerase activity. Each preparation was transcribed with either added Escherichia coli or partially purified rat liver nucleoplasmic RNA polymerase. With either polymerase or chromatin preparation, no inhibition of the template activity of liver nuclear chromatin isolated from the DMN-treated animals was detected. A similar mechanism of inhibition of RNA synthesis was produced by the action of the methylating agent methyl methanesulfonate on whole nuclei in vitro. The dose-dependent inhibition of RNA synthesis could be accounted for by an inhibition of the RNA polymerase activities quantitatively solubilized and partially purified from the affected nuclei. Chromatin prepared from the methyl methanesulfonate-treated nuclei had a normal template capacity with either E. coli or rat liver nucleoplasmic RNA polymerase. No preferential methylation of the RNA polymerases by [14C]methyl methanesulfonate could be demonstrated. It is concluded that the action of the two methylating agents on RNA metabolism is similar and that the inhibition of liver nuclear RNA synthesis results from inactivation of the RNA polymerases. At the same time, dimethylnitrosamine and methyl methanesulfonate leave the chromatin template intact, at least quantitatively, for the synthesis of RNA. The implications of such an effect on RNA synthesis are discussed.
二甲基亚硝胺以40毫克/千克体重的剂量可使大鼠肝细胞核RNA合成最大程度地抑制50%。这种抑制在最初4小时内出现,并持续到第12小时。肝小叶的所有实质细胞似乎都受到影响。RNA合成的减少完全可归因于对定量溶解和部分纯化的RNA聚合酶活性的抑制。通过用放线菌素D使内源性模板失活并用添加的外源模板聚(脱氧腺苷酸-脱氧胸苷酸)测定聚合酶,在完整细胞核中也证明了聚合酶活性有类似的抑制。通过两种方法制备染色质,这两种方法在去除内源性聚合酶活性的程度上有所不同。每种制备物都用添加的大肠杆菌或部分纯化的大鼠肝核质RNA聚合酶进行转录。无论是使用哪种聚合酶或染色质制备物,均未检测到从经二甲基亚硝胺处理的动物分离的肝细胞核染色质的模板活性受到抑制。甲基化剂甲磺酸甲酯在体外对完整细胞核的作用产生了类似的RNA合成抑制机制。RNA合成的剂量依赖性抑制可归因于对从受影响细胞核中定量溶解和部分纯化的RNA聚合酶活性的抑制。从甲磺酸甲酯处理的细胞核制备的染色质对于大肠杆菌或大鼠肝核质RNA聚合酶具有正常的模板能力。未证明[14C]甲磺酸甲酯对RNA聚合酶有优先甲基化作用。得出的结论是,这两种甲基化剂对RNA代谢的作用相似,并且肝细胞核RNA合成的抑制是由RNA聚合酶的失活导致的。同时,二甲基亚硝胺和甲磺酸甲酯至少在定量上使染色质模板保持完整以用于RNA合成。讨论了这种对RNA合成的影响的意义。